IQVIA Holdings Inc. (IQV) Price Target Analysis

Updated Jun 18, 2026

Analyst Rating: Buy

Based on 44 analysts

30.8% Below Target

IQV trades 30.8% below Wall Street's consensus target of $219.44.

Current Price$167.77

Average Target$219.44

Target

Current

Low$185.00

Median$215.00

High$250.00

Analyst Target Range

Forward P/E13.1x

(Value)

PEG Ratio0.32

(Undervalued)

Implied Growth+57.2%

(High Growth)

Analyst Spread29.6%

(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$167.77

Consensus$219.44

High$250.00

Low$185.00

Consensus Scenario Assumptions

The base valuation assumes IQV achieves its forward estimates and maintains a stable P/E multiple of 13.1x. This scenario reflects the blended consensus of 44 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 44 published analyst recommendations for IQV

37/44 analysts are bullish

BearishBullish

Weighted analyst sentiment score based on 44 ratings

ConsensusBuy

Coverage44 Analysts

Net Score+42

Bull / Bear84% / 2%

Strong Buy12%

Buy3682%

Hold614%

Sell12%

Strong Sell00%

Strong Buy

12%

Buy

3682%

Hold

614%

Sell

12%

Strong Sell

00%

Recommendation Mix84% Buy · 14% Hold · 2% Sell

Buy (37)Hold (6)Sell (1)

IQV Price Target Analysis

Updated June 21, 2026

As of June 21, 2026, IQVIA Holdings Inc. (IQV) has a Wall Street consensus price target of $219.44, based on estimates from 44 covering analysts. With the stock currently trading at $167.77, this represents a potential upside of +30.8%. The company has a market capitalization of $28.47B.

Analyst price targets range from a low of $185.00 to a high of $250.00, representing a 30% spread in expectations. The median target of $215.00 aligns closely with the consensus average.

The current analyst consensus rating is Buy, with 37 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, IQV trades at a trailing P/E of 21.4x and forward P/E of 13.1x. The forward PEG ratio of 0.32 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +57.2% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $273.40, with bear and bull scenarios of $172.24 and $360.23 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis

Avg Peer Upside

+10.1%

Industry Consensus

Avg Forward P/E

77.0x

(High Premium)

Peers with Coverage

10 / 10

Active Analyst Tracking

Company	Market Cap	Price	Target	Upside Potential	Rating	Fwd P/E	Analysts
CRLCharles River Laboratories International, Inc.	$8.9B	$185.00	$214.14	+15.8%	Buy	16.7x	37
ICLRICON Public Limited Company	$11.2B	$146.00	$139.90	-4.2%	Buy	13.8x	30
PRAProAssurance Corporation	$1.3B	$24.65	$18.33	-25.6%	Hold	20.1x	11
MEDPMedpace Holdings, Inc.	$13.1B	$460.20	$498.86	+8.4%	Hold	27.1x	19
VEEVVeeva Systems Inc.	$24.9B	$153.30	$235.38	+53.5%	Buy	16.9x	43
INCYIncyte Corporation	$19.6B	$98.22	$109.80	+11.8%	Buy	13.0x	44
EXASExact Sciences Corporation	$20.0B	$104.91	$105.00	+0.1%	Buy	582.8x	41
HCATHealth Catalyst, Inc.	$129M	$1.74	$2.25	+29.3%	Buy	44.8x	22
UNHUnitedHealth Group Incorporated	$363.9B	$400.96	$425.81	+6.2%	Buy	21.8x	52
CVSCVS Health Corporation	$125.4B	$98.32	$103.64	+5.4%	Buy	13.3x	41

IQV — Frequently Asked Questions

Quick answers to the most common questions about buying IQV stock.

What is the IQV stock price target for 2026?

The consensus Wall Street price target for IQV is $219.44, representing 30.8% upside from the current price of $167.77. With 44 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is IQV a buy, sell, or hold?

IQV has a consensus rating of "Buy" based on 44 Wall Street analysts. The rating breakdown is predominantly bullish, with 37 Buy/Strong Buy ratings. The consensus 12-month price target of $219.44 implies 30.8% upside from current levels.

Is IQV stock overvalued or undervalued?

With a forward P/E of 13.0869x, IQV trades at a relatively low valuation. The consensus target of $219.44 implies 30.8% appreciation, suggesting meaningful undervaluation.

How high can IQV stock go?

The most bullish Wall Street analyst has a price target of $250 for IQV, while the most conservative target is $185. The consensus of $219.44 represents the median expectation. Our quantitative valuation model projects a bull case target of $360 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover IQV stock?

IQV is heavily covered by Wall Street, with 44 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 36 have Buy ratings, 6 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the IQV stock forecast?

The 12-month IQV stock forecast based on 44 Wall Street analysts shows a consensus price target of $219.44, with estimates ranging from $185 (bear case) to $250 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $273, with bear/bull scenarios of $172/$360.

What is IQV's fair value based on fundamentals?

Our quantitative valuation model calculates IQV's fair value at $273 (base case), with a bear case of $172 and bull case of $360. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.

What is IQV's forward P/E ratio?

IQV trades at a forward P/E ratio of 13.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 21.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy IQV stock?

Wall Street analysts are very optimistic on IQV, with a "Buy" consensus rating and $219.44 price target (30.8% upside). 37 of 44 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do IQV price targets vary so much?

IQV analyst price targets range from $185 to $250, a 30% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $219.44 consensus represents the middle ground. Our model's $172-$360 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools